https://finance.yahoo.com/news/immunogen-touts-additional-positive-data-154516127.html
0
0
ImmunoGen Touts Additional Positive Data From Ovarian Cancer Drug, Seeks Expanded Use Approval, Stock Soars - Yahoo Finance
5/3/23 at 3:45pm
Organization
Yahoo Entertainment
Author
Vandana Singh
Details
42 words
Summarize
Business & Industrial Health ImmunoGen GOG 3045 Use Approval Ovarian Cancer Drug Yahoo Finance ImmunoGen Inc Nasdaq IMGN
ImmunoGen Inc (NASDAQ: IMGN) shares are shooting higher on Wednesday after it announced top-line data from the Phase 3 confirmatory MIRASOL trial (GOG 3045...
Create an account or login to join the discussion